Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol

The Journal of pharmacy and pharmacology

Volumn 66, Issue 12, 2014, Pages 1677-1685

  Grekas, Nikolaos ^a   Athanassiou, Katerina ^a   Papataxiarchou, Katerina ^a   Rizea Savu, Simona ^a   Silvestro, Luigi ^a  

^a ELPEN Pharmaceutical Co Inc   (Greece)

Author keywords

bioequivalence; dry powder inhaler; formulation; pharmacokinetics; pulmonary deposition

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FORMOTEROL;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ASTHMA; BLOOD; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG COMBINATION; DRY POWDER INHALER; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; THERAPEUTIC EQUIVALENCE; TISSUE DISTRIBUTION; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CROSS-OVER STUDIES; DRUG COMBINATIONS; DRY POWDER INHALERS; ETHANOLAMINES; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; THERAPEUTIC EQUIVALENCY; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84910665974     PISSN: None     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12303     Document Type: Article

References (0)